- Home
- VAC vs ACAD Comparison
VAC vs ACAD Comparison
Compare VAC & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAC
- ACAD
- Stock Information
- Founded
- VAC 1984
- ACAD 1993
- Country
- VAC United States
- ACAD United States
- Employees
- VAC N/A
- ACAD N/A
- Industry
- VAC Real Estate
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- VAC Finance
- ACAD Health Care
- Exchange
- VAC Nasdaq
- ACAD Nasdaq
- Market Cap
- VAC 3.4B
- ACAD 2.9B
- IPO Year
- VAC N/A
- ACAD 2004
- Fundamental
- Price
- VAC $91.49
- ACAD $17.37
- Analyst Decision
- VAC Buy
- ACAD Buy
- Analyst Count
- VAC 9
- ACAD 18
- Target Price
- VAC $106.22
- ACAD $26.53
- AVG Volume (30 Days)
- VAC 265.2K
- ACAD 1.6M
- Earning Date
- VAC 02-19-2025
- ACAD 02-25-2025
- Dividend Yield
- VAC 3.35%
- ACAD N/A
- EPS Growth
- VAC N/A
- ACAD N/A
- EPS
- VAC 5.26
- ACAD 0.78
- Revenue
- VAC $3,194,000,000.00
- ACAD $929,236,000.00
- Revenue This Year
- VAC $55.75
- ACAD $37.34
- Revenue Next Year
- VAC $5.13
- ACAD $7.25
- P/E Ratio
- VAC $17.42
- ACAD $22.37
- Revenue Growth
- VAC N/A
- ACAD 47.06
- 52 Week Low
- VAC $67.28
- ACAD $14.15
- 52 Week High
- VAC $108.57
- ACAD $31.92
- Technical
- Relative Strength Index (RSI)
- VAC 47.80
- ACAD 54.74
- Support Level
- VAC $88.50
- ACAD $16.27
- Resistance Level
- VAC $91.40
- ACAD $17.86
- Average True Range (ATR)
- VAC 2.34
- ACAD 0.77
- MACD
- VAC -0.94
- ACAD -0.08
- Stochastic Oscillator
- VAC 30.67
- ACAD 39.57
About VAC Marriott Vacations Worldwide Corporation
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.